These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 20530323)
1. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. De Stefano N; Giorgio A; Battaglini M; Rovaris M; Sormani MP; Barkhof F; Korteweg T; Enzinger C; Fazekas F; Calabrese M; Dinacci D; Tedeschi G; Gass A; Montalban X; Rovira A; Thompson A; Comi G; Miller DH; Filippi M Neurology; 2010 Jun; 74(23):1868-76. PubMed ID: 20530323 [TBL] [Abstract][Full Text] [Related]
2. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA. Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288 [TBL] [Abstract][Full Text] [Related]
7. Gray matter atrophy in multiple sclerosis: a longitudinal study. Fisher E; Lee JC; Nakamura K; Rudick RA Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561 [TBL] [Abstract][Full Text] [Related]
8. Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis. Jasperse B; Minneboo A; de Groot V; Kalkers NF; van Helden PE; Uitdehaag BM; Barkhof F; Polman CH Arch Neurol; 2007 Feb; 64(2):190-4. PubMed ID: 17296834 [TBL] [Abstract][Full Text] [Related]
9. One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging. Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergström J; Flodmark O; Aspelin P; Wiberg MK Acta Radiol; 2009 Oct; 50(8):924-32. PubMed ID: 19639474 [TBL] [Abstract][Full Text] [Related]
10. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis. Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193 [TBL] [Abstract][Full Text] [Related]
11. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086 [TBL] [Abstract][Full Text] [Related]
12. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study. Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104 [TBL] [Abstract][Full Text] [Related]
13. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study. Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003 [TBL] [Abstract][Full Text] [Related]
14. Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics? Korteweg T; Rovaris M; Neacsu V; Filippi M; Comi G; Uitdehaag BM; Knol DL; Polman CH; Barkhof F; Vrenken H; Mult Scler; 2009 Apr; 15(4):465-71. PubMed ID: 19091881 [TBL] [Abstract][Full Text] [Related]
15. MRI as an outcome in multiple sclerosis clinical trials. Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945 [TBL] [Abstract][Full Text] [Related]
16. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349 [TBL] [Abstract][Full Text] [Related]
17. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256 [TBL] [Abstract][Full Text] [Related]
18. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Gordon-Lipkin E; Chodkowski B; Reich DS; Smith SA; Pulicken M; Balcer LJ; Frohman EM; Cutter G; Calabresi PA Neurology; 2007 Oct; 69(16):1603-9. PubMed ID: 17938370 [TBL] [Abstract][Full Text] [Related]
19. Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Tedeschi G; Lavorgna L; Russo P; Prinster A; Dinacci D; Savettieri G; Quattrone A; Livrea P; Messina C; Reggio A; Bresciamorra V; Orefice G; Paciello M; Brunetti A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Patti F; Salemi G; Cammarata E; Simone IL; Salvatore M; Bonavita V; Alfano B Neurology; 2005 Jul; 65(2):280-5. PubMed ID: 16043800 [TBL] [Abstract][Full Text] [Related]
20. Gender-related differences in MS: a study of conventional and nonconventional MRI measures. Antulov R; Weinstock-Guttman B; Cox JL; Hussein S; Durfee J; Caiola C; Dwyer MG; Bergsland N; Abdelrahman N; Stosic M; Hojnacki D; Munschauer FE; Miletic D; Zivadinov R Mult Scler; 2009 Mar; 15(3):345-54. PubMed ID: 19028830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]